Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

84.000
-0.200-0.24%
Volume:1.98M
Turnover:163.02M
Market Cap:106.51B
PE:75.00
High:84.300
Open:82.050
Low:80.600
Close:84.200
52wk High:85.000
52wk Low:43.500
Shares:1.27B
HK Float Shares:1.27B
Volume Ratio:0.60
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.120
ROE:16.33%
ROA:9.32%
PB:8.05
PE(LYR):75.00
PS:13.10

Loading ...

Movement Alert|WUXI XDC Falls 3.38% in Regular Trading, Life Sciences Tools & Services Sector Under Broad Pressure

Market Focus
·
Yesterday

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

Movement Alert|WUXI XDC Rises 3.02% in Regular Trading, Trading at HK$83.65

Market Focus
·
Oct 06

Movement Alert|WUXI XDC Falls 3.66% in Regular Trading, Major Shareholder Reduction Overhang Persists Amid Broad Sector Weakness

Market Focus
·
Oct 02

WuXi XDC Shares In Focus After Singapore Plant Approval

Simply Wall St.
·
Oct 01

Goldman Sachs: Asian CDMOs Enter a Structural Growth Cycle, with Peptides, ADCs, Oligonucleotides, and AIDD as New Engines

Stock News
·
Sep 30

Movement Alert|WUXI XDC Rises 3.01% in Regular Trading, Sector Rebound Coupled with New Strategic Investment Expansion

Market Focus
·
Sep 30

Movement Alert|WUXI XDC Falls 3.34% in Regular Trading, Major Shareholder Reduction Ripple Effect Compounds Sector Weakness

Market Focus
·
Sep 29

Movement Alert|WUXI XDC Falls 3.02% in Regular Trading, Life Sciences Sector Under Broad Pressure Amid Lingering Shareholder Reduction Overhang

Market Focus
·
Sep 28

Goldman Sachs assigns Buy rating to Wuxi XDC with HK$97.90 target price

Deep News
·
Sep 27

Goldman Sachs: WuXi XDC's Commercial Manufacturing Validation Seen as Key Long-Term Visibility Catalyst

Stock News
·
Sep 25

China's Roadmap for Pharmaceuticals May Support Sector Development

Dow Jones
·
Sep 21

Movement Alert|WUXI XDC Rises 3.51% in Regular Trading, Morgan Stanley Reaffirms Overweight Rating with 85 HKD Target as Sector Rallies

Market Focus
·
Sep 21

Morgan Stanley Reiterates Overweight Call on WUXI XDC, Sets Target at HK$85

Deep News
·
Sep 20

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Reuters
·
Sep 17

Movement Alert|WUXI XDC Rises 3.01% in Regular Trading, Schroders Increases Stake Past 5% Disclosure Threshold

Market Focus
·
Sep 17

Schroders PLC Raises Stake in WUXI XDC with HK$29.85M Share Purchase

Stock News
·
Sep 16

WUXI XDC: Schroders PLC Acquires Shares, Long Position Rises to 5.01%

HK Disclosure
·
Sep 16

WUXI XDC: Schroders PLC Disposes of Shares, Long Position Falls to 4.98%

HK Disclosure
·
Sep 15

Movement Alert|WUXI XDC Rises 3.81% in Regular Trading, Sector-Wide Rebound and Strong Interim Results Provide Dual Support

Market Focus
·
Sep 14